International Centre For Diarrhoeal Disease Research, Bangladesh
Clinical trials sponsored by International Centre For Diarrhoeal Disease Research, Bangladesh, explained in plain language.
-
Common drug tested for mysterious skin disease linked to parasite outbreaks
Disease control CompletedThis early study tested whether oral ivermectin could safely treat PKDL, a skin disease that appears after recovery from kala-azar (visceral leishmaniasis). Researchers compared ivermectin taken for three months against the standard 12-week miltefosine treatment in 30 patients in…
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Common drug tested for stubborn skin disease
Disease control CompletedThis small, early study tested if the drug ivermectin, taken by mouth, is safe and can help treat Post Kala-Azar Dermal Leishmaniasis (PKDL). PKDL is a skin condition that can appear after someone recovers from kala-azar (visceral leishmaniasis). The study involved 10 participant…
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Does early help for moms boost Kids' brains years later?
Knowledge-focused CompletedThis study followed up on children in Bangladesh to see if a program from their infancy had lasting effects. The original program gave some mothers parenting guidance along with small cash payments, while others received only cash. Researchers checked years later, when the childr…
Phase: NA • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC